Kangstem Biotech Co., Ltd. (KOSDAQ:217730)

Kangstem Biotech Revenue

Kangstem Biotech had revenue of 783.33M KRW in the quarter ending September 30, 2024, a decrease of -39.10%. This brings the company's revenue in the last twelve months to 12.77B, up 30.25% year-over-year. In the year 2023, Kangstem Biotech had annual revenue of 12.70B, down -22.06%.

• Revenue (ttm): 12.77B
• Revenue Growth: +30.25%
• P/S Ratio: 16.12
• Revenue / Employee: 131.70M
• Employees: 97
• Market Cap: 205.98B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	12.70B	-3.60B	-22.06%
Dec 31, 2022	16.30B	3.90B	31.41%
Dec 31, 2021	12.40B	3.27B	35.75%
Dec 31, 2020	9.14B	3.13B	52.18%
Dec 31, 2019	6.00B	-3.16B	-34.49%